C07C 237/52
Carboxylic acid amides, the carbon skeleton of the acid part being further
Official title: having the nitrogen atom of at least one of the carboxamide groups further acylated
C07C237/52 (Carboxylic acid amides, the carbon skeleton of the acid part being further) appears on 57 US grants and 90 published applications in this corpus.
Search patents in C07C- Granted patents
- 57
- Published applications
- 90
- Assignees
- 63
- Inventors
- 253
- Latest grant
- 24 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 1 |
| 2003 | 1 | 2 |
| 2004 | 2 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 2 |
| 2013 | 0 | 2 |
| 2014 | 2 | 7 |
| 2015 | 6 | 7 |
| 2016 | 3 | 7 |
| 2017 | 7 | 10 |
| 2018 | 0 | 6 |
| 2019 | 8 | 6 |
| 2020 | 0 | 1 |
| 2021 | 3 | 1 |
| 2022 | 2 | 6 |
| 2023 | 3 | 8 |
| 2024 | 3 | 3 |
| 2025 | 3 | 10 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bis-octahydrophenanthrene carboxamides and protein conjugates thereof24 Jun 2025US 12,338,199 B2Regeneron Pharmaceuticals, Inc.
- Dichlorophenol HSD17B13 inhibitors and uses thereof18 Feb 2025US 12,227,489 B2Inipharm, Inc.
- Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists28 Jan 2025US 12,209,180 B2Regeneron Pharmaceuticals, Inc.
- Preparation of cationic surfactants28 May 2024US 11,993,553 B2Saudi Arabian Oil Company
- Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto2 Apr 2024US 11,944,099 B2Corteva Agriscience LLC
- Lipid formulation using multi-component condensation reaction and lipid nanoparticles made using the same3 Sep 2026US 2026/0256707 A1Oregon State University
- Method for quantitatively analyzing polysulfide in sample27 Aug 2026US 2026/0250239 A1Bio-Xcelerator, Inc.
- Solid forms of rxfp1 modulators20 Aug 2026US 2026/0240798 A1AstraZeneca AB
- Bacterial compositions and methods of use19 Mar 2026US 2026/0077001 A1University of Florida Research Foundation, Inc.
- Compositions and methods of use12 Mar 2026US 2026/0069560 A1University of Florida Research Foundation, Inc.
Most cited
By later US patents
- Anticonvulsant enantiomeric amino acid derivatives46US 5,773,475 AResearch Corporation Technologies, Inc. · 1998
- Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use28US 5,880,147 ASankyo Company, Limited · 1999
- Urea derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use27US 6,040,339 ASankyo Company, Limited · 2000
- Anticonvulsant enantiomeric amino acid derivatives21US 6,048,899 AResearch Corporation Tech., Inc. · 2000
- Acetamidobenzamide compounds for neurodegenerative disorders15US 5,756,548 ACentaur Pharmaceuticals, Inc. · 1998